December 3, 2019
Astellas Moves into Gene Therapy with $3 Billion Acquisition of Audentes
Read More
December 2, 2019
Neurocrine and Xenon Partner to Develop Treatment for Rare Epilepsy
Read More
November 19, 2019
Dicerna and Novo Nordisk Partner in RNAi Therapies for Liver Diseases
Read More
November 18, 2019
Roche Beefs Up Its Fibrosis Pipeline in $1.4 Billion Deal to Acquire Promedior
Read More
November 15, 2019
Sarepta and StrideBio Collaborate to Advance Novel Gene Therapies
Read More
November 14, 2019
Centogene and Pfizer Collaborate for Rare Disease Drug Development
Read More
November 13, 2019
Merck Acquires Calporta for Up to $576 Million
Read More
October 31, 2019
Beam Therapeutics Teams with Prime Medicine for Prime Editing Technology
Read More
October 30, 2019
Vertex Exercises Cystic Fibrosis Gene Editing Options from CRISPR Therapeutics
Read More
October 24, 2019
New Biotech Allievex Licenses BioMarin’s Sanfilippo ERT
Read More
October 16, 2019
Editas and AskBio Team Up to Develop Novel Treatments for Neurological Diseases
Read More
October 16, 2019
Ipsen Expands Its Rare Disease Portfolio with License for Blueprint Medicines’ FOP Treatment
Read More
Load More
X